Refractory or Recurrent Solid Tumor
1 clinical trials · Condition
◉ Watch Refractory or Recurrent Solid Tumor
| Record | Firm | Date |
|---|---|---|
| Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults (NCT05210413) | University Hospital, Bordeaux | 2022-05-17 |
Track Refractory or Recurrent Solid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.